Summary
45 / 100 · Bulios Score
What speaks for it
- Analysts expect revenue to grow by 43% this fiscal year.
- It bought back its own shares for £31.2M in the last fiscal year, 3.7% of its market value.
What to watch
- Earnings per share fell by 26% a year over the last 3 years.
- The share price is above the Bulios Fair Price.
- It missed profit estimates 8 times in the last 8 quarters.
- Out of every 100 GBP of revenue, only 2.4 GBP is left as net profit.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 49.2 GBP for 1 GBP of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (GBP)
Diluted EPS (GBP)
- Analyst estimate
Revenue grew by 6.6% a year over 5 years. Over the last 3 years it grew by 6.0% a year. For the next fiscal year analysts expect revenue to grow by 43%. Earnings per share fell by 26% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 GBP of revenue goes
- Cost of sales 59 GBP
- Sales and administration 30 GBP
- Taxes and other 8.4 GBP
- Net profit 2.4 GBP
Net profit, industry median (Medical - Care Facilities) 6.7 GBP
Out of every 100 GBP of revenue, 2.4 GBP is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 7.4 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 0.67%
- Paid out of profit
- 33%
- Raised in a row
- 4 years
You receive $0.11 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 2
- Hold 0
- Sell 0
No analyst has published a price target.
100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.